9886 — Dingdang Health Technology Income Statement
0.000.00%
- HK$1.39bn
- HK$200.42m
- CNY4.67bn
- 37
- 55
- 95
- 72
Annual income statement for Dingdang Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,229 | 3,679 | 4,329 | 4,857 | 4,669 |
| Cost of Revenue | |||||
| Gross Profit | 766 | 1,162 | 1,450 | 1,511 | 1,538 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,120 | 5,243 | 7,153 | 5,068 | 5,029 |
| Operating Profit | -892 | -1,564 | -2,824 | -211 | -360 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -901 | -1,582 | -2,832 | -221 | -370 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -920 | -1,599 | -2,842 | -231 | -380 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -924 | -1,578 | -2,833 | -226 | -376 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -924 | -1,578 | -2,833 | -226 | -376 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.688 | -1.16 | -3.33 | -0.168 | -0.182 |